Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome)-Reference-Cited by-同舟云学术

Open-label study evaluating outpatient urethral sphincter injections of onabotulinumtoxinA to treat women with urinary retention due to a primary disorder of sphincter relaxation (Fowler's syndrome)

Published:2015-11-08 Issue:5 Volume:117 Page:809-813
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Panicker Jalesh N.¹,Seth Jai H.¹,Khan Shahid¹,Gonzales Gwen¹,Haslam Collette¹,Kessler Thomas M.²,Fowler Clare J.¹

Affiliation:

1. Department of Uro-Neurology; The National Hospital for Neurology and Neurosurgery; University College London (UCL); Institute of Neurology; London UK

2. Neuro-Urology; Spinal Cord Injury Centre; Balgrist University Hospital; University of Zürich; Zürich Switzerland

Funder

Department of Health a National Institute for Health Research

The Urology Foundation and the InComb project

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13342/fullpdf

Reference21 articles.

1. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome?;Fowler;BMJ,1988